All Stories

  1. Late Breaking Abstract - Real-life rapidity of dupilumab effects on symptom control, lung function and prednisone intake in patients with severe eosinophilic asthma and nasal polyposis

    Article • September 2021, European Respiratory Society (ERS)

    Corrado Pelaia

  2. Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use

    Article • F1000Research, June 2020, Faculty of 1000, Ltd.

    Corrado Pelaia, Claudia Crimi, Santi Nolasco

  3. Real-life treatment of severe eosinophilic asthma with mepolizumab

    Article • September 2019, European Respiratory Society (ERS)

    Corrado Pelaia

  4. Recognizing, quantifying and managing patient-ventilator asynchrony in invasive and noninvasive ventilation

    Article • Expert Review of Respiratory Medicine, May 2018, Taylor & Francis

    Eugenio Garofalo, Corrado Pelaia

  5. Benralizumab in the treatment of severe asthma: design, development and potential place in therapy

    Article • Drug Design Development and Therapy, March 2018, Dove Medical Press

    Corrado Pelaia

  6. Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma

    Article • BioMed Research International, January 2018, Hindawi Publishing Corporation

    Maria Teresa Busceti, Eugenio Garofalo, Corrado Pelaia

  7. Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

    Article • Drug Design Development and Therapy, October 2017, Dove Medical Press

    Maria Teresa Busceti, Dr Luca Gallelli, Corrado Pelaia

  8. Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy

    Article • Expert Opinion on Pharmacotherapy, April 2017, Taylor & Francis

    Corrado Pelaia